{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T09:07:56Z","timestamp":1778836076238,"version":"3.51.4"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"vor","delay-in-days":5,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100022896","name":"Singapore Immunology Network","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022896","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001348","name":"Agency for Science, Technology and Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["SIgN 10-037"],"award-info":[{"award-number":["SIgN 10-037"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","translationalres.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.trsl.2026.01.002","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T17:09:49Z","timestamp":1767719389000},"page":"1-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["B-cell activation underpins Rituximab response in focal segmental glomerulosclerosis"],"prefix":"10.1016","volume":"287","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8363-4353","authenticated-orcid":false,"given":"Liangjian","family":"Lu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5841-1417","authenticated-orcid":false,"given":"Chang Yien","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mya","family":"Than","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon","family":"Teo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Perry YW","family":"Lau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kong-Peng","family":"Lam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kar Hui","family":"Ng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui Kim","family":"Yap","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.trsl.2026.01.002_bib0001","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.28701","article-title":"Comparing kidney health outcomes in children, adolescents, and adults with focal segmental glomerulosclerosis","volume":"5","author":"Gipson","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"3","key":"10.1016\/j.trsl.2026.01.002_bib0002","doi-asserted-by":"crossref","first-page":"502","DOI":"10.2215\/CJN.05960616","article-title":"Focal segmental glomerulosclerosis","volume":"12","author":"Rosenberg","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.trsl.2026.01.002_bib0003","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1247606","article-title":"Current understanding of the molecular mechanisms of circulating permeability factor in focal segmental glomerulosclerosis","volume":"14","author":"Salfi","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.trsl.2026.01.002_bib0004","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1379924","article-title":"A novel flow cytometry panel to identify prognostic markers for steroid-sensitive forms of idiopathic nephrotic syndrome in childhood","volume":"15","author":"Riganati","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.trsl.2026.01.002_bib0005","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3389\/fped.2019.00377","article-title":"Altered B-lymphocyte homeostasis in idiopathic nephrotic syndrome","volume":"7","author":"Ling","year":"2019","journal-title":"Front pediatr"},{"key":"10.1016\/j.trsl.2026.01.002_bib0006","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.726428","article-title":"CyTOF-enabled analysis identifies class-switched B cells as the main lymphocyte subset associated with disease relapse in children with idiopathic nephrotic syndrome","volume":"12","author":"Fribourg","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.trsl.2026.01.002_bib0007","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.823204","article-title":"B-cell dysregulation in idiopathic nephrotic syndrome: what we know and what we need to discover","volume":"13","author":"Colucci","year":"2022","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.trsl.2026.01.002_bib0008","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.kint.2023.06.013","article-title":"Age and memory B cells at baseline are associated with risk of relapse and memory B-cell reappearance following anti-CD20 treatment in pediatric frequently-relapsing\/steroid-dependent nephrotic syndrome","volume":"104","author":"Colucci","year":"2023","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.trsl.2026.01.002_bib0009","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1681\/ASN.2015050523","article-title":"B cell reconstitution after Rituximab treatment in idiopathic nephrotic syndrome","volume":"27","author":"Colucci","year":"2016","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"10.1016\/j.trsl.2026.01.002_bib0010","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1038\/s41390-022-02336-w","article-title":"B cell phenotype, activity, and function in idiopathic nephrotic syndrome","volume":"93","author":"Liu","year":"2023","journal-title":"Pediatr Res"},{"issue":"256","key":"10.1016\/j.trsl.2026.01.002_bib0011","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3008538","article-title":"A circulating antibody panel for pretransplant prediction of FSGS recurrence after kidney transplantation","volume":"6","author":"Delville","year":"2014","journal-title":"Sci Transl Med"},{"issue":"3","key":"10.1016\/j.trsl.2026.01.002_bib0012","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.kint.2023.11.022","article-title":"A multi-institutional study found a possible role of anti-nephrin antibodies in post-transplant focal segmental glomerulosclerosis recurrence","volume":"105","author":"Shirai","year":"2024","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.trsl.2026.01.002_bib0013","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1056\/NEJMoa2314471","article-title":"Autoantibodies targeting Nephrin in podocytopathies","volume":"391","author":"Hengel Felicitas","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2026.01.002_bib0014","doi-asserted-by":"crossref","unstructured":"Chan C.Y., Liu I.D., Resontoc L.P., et al. T lymphocyte activation markers as predictors of responsiveness to Rituximab among patients with FSGS..Clin J Am Soc Nephrol Aug 8 2016;11(8):1360-8. doi:10.2215\/cjn.11941115.","DOI":"10.2215\/CJN.11941115"},{"issue":"3","key":"10.1016\/j.trsl.2026.01.002_bib0015","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s00467-022-05739-3","article-title":"IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome","volume":"38","author":"Trautmann","year":"2023","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.trsl.2026.01.002_bib0016","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.trsl.2021.03.019","article-title":"Low regulatory T-cells: a distinct immunological subgroup in minimal change nephrotic syndrome with early relapse following rituximab therapy","volume":"235","author":"Chan","year":"2021","journal-title":"Transl Res"},{"issue":"2","key":"10.1016\/j.trsl.2026.01.002_bib0017","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1073\/pnas.98.2.646","article-title":"Conditional immortalization of freshly isolated human mammary fibroblasts and endothelial cells","volume":"98","author":"O'Hare","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.trsl.2026.01.002_bib0018","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1681\/ASN.V133630","article-title":"A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression","volume":"13","author":"Saleem","year":"2002","journal-title":"J Am Soc Nephrol"},{"issue":"24","key":"10.1016\/j.trsl.2026.01.002_bib0019","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1042\/CS20160312","article-title":"Novel role of Vav1-Rac1 pathway in actin cytoskeleton regulation in interleukin-13-induced minimal change-like nephropathy","volume":"130","author":"Chan","year":"2016","journal-title":"Clin Sci (L)"},{"issue":"12","key":"10.1016\/j.trsl.2026.01.002_bib0020","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1007\/s00109-008-0399-y","article-title":"Mechanisms of angiotensin II signaling on cytoskeleton of podocytes","volume":"86","author":"Hsu","year":"2008","journal-title":"J Mol Med"},{"issue":"2","key":"10.1016\/j.trsl.2026.01.002_bib0021","doi-asserted-by":"crossref","first-page":"890","DOI":"10.4049\/jimmunol.182.2.890","article-title":"Resting human memory B cells are intrinsically programmed for enhanced survival and responsiveness to diverse stimuli compared to naive B cells","volume":"182","author":"Good","year":"2009","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.trsl.2026.01.002_bib0022","doi-asserted-by":"crossref","first-page":"5669","DOI":"10.4049\/jimmunol.167.10.5669","article-title":"Immunological memory: contribution of memory B cells expressing costimulatory molecules in the resting state","volume":"167","author":"Bar-Or","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.trsl.2026.01.002_bib0023","doi-asserted-by":"crossref","unstructured":"Al-Aubodah TA, Aoudjit L., Pascale G., et al. The extrafollicular B cell response is a hallmark of childhood idiopathic nephrotic syndrome..Nat Commun Nov 24 2023; 14(1):7682. doi:10.1038\/s41467-023-43504-8.","DOI":"10.1038\/s41467-023-43504-8"},{"issue":"6","key":"10.1016\/j.trsl.2026.01.002_bib0024","doi-asserted-by":"crossref","first-page":"F1683","DOI":"10.1152\/ajprenal.00512.2017","article-title":"Podocytes contribute, and respond, to the inflammatory environment in lupus nephritis","volume":"315","author":"Wright","year":"2018","journal-title":"Am J Physiol Ren Physiol"},{"issue":"21","key":"10.1016\/j.trsl.2026.01.002_bib0025","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.81836","article-title":"B cell-derived IL-4 acts on podocytes to induce proteinuria and foot process effacement","volume":"2","author":"Kim","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.trsl.2026.01.002_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.154804","article-title":"The IL-8-CXCR1\/2 axis contributes to diabetic kidney disease","volume":"121","author":"Loretelli","year":"2021","journal-title":"Metabolism"},{"key":"10.1016\/j.trsl.2026.01.002_bib0027","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.922193","article-title":"Serum IL-12p40: a novel biomarker for early prediction of minimal change disease relapse following glucocorticoids therapy","volume":"9","author":"Bai","year":"2022","journal-title":"Front Med"},{"issue":"5","key":"10.1016\/j.trsl.2026.01.002_bib0028","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1681\/ASN.2006070710","article-title":"Overexpression of interleukin-13 induces minimal-change-like nephropathy in rats","volume":"18","author":"Lai","year":"2007","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.trsl.2026.01.002_bib0029","doi-asserted-by":"crossref","DOI":"10.1111\/sji.12645","article-title":"Interleukin-17A participates in podocyte injury by inducing IL-1beta secretion through ROS-NLRP3 inflammasome-caspase-1 pathway","volume":"87","author":"Yan","year":"2018","journal-title":"Scand J Immunol"},{"issue":"1","key":"10.1016\/j.trsl.2026.01.002_bib0030","doi-asserted-by":"crossref","first-page":"F85","DOI":"10.1152\/ajprenal.90642.2008","article-title":"The monocyte chemoattractant protein-1\/CCR2 loop, inducible by TGF-beta, increases podocyte motility and albumin permeability","volume":"297","author":"Lee","year":"2009","journal-title":"Am J Physiol Ren Physiol"},{"key":"10.1016\/j.trsl.2026.01.002_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114450","article-title":"Macrophage inflammatory protein-1beta as a novel therapeutic target for renal protection in diabetic kidney disease","volume":"161","author":"Chang","year":"2023","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"10.1016\/j.trsl.2026.01.002_bib0032","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.kint.2022.10.023","article-title":"Precision nephrology identified tumor necrosis factor activation variability in minimal change disease and focal segmental glomerulosclerosis","volume":"103","author":"Mariani","year":"2023","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.trsl.2026.01.002_bib0033","doi-asserted-by":"crossref","first-page":"332","DOI":"10.2215\/CJN.05000516","article-title":"Minimal change disease","volume":"12","author":"Vivarelli","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.trsl.2026.01.002_bib0034","doi-asserted-by":"crossref","first-page":"F685","DOI":"10.1152\/ajprenal.00219.2023","article-title":"Idiopathic\" minimal change nephrotic syndrome: a podocyte mystery nears the end","volume":"325","author":"Chugh","year":"2023","journal-title":"Am J Physiol Ren Physiol"},{"issue":"4","key":"10.1016\/j.trsl.2026.01.002_bib0035","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.kint.2018.05.022","article-title":"JAK-STAT signaling is activated in the kidney and peripheral blood cells of patients with focal segmental glomerulosclerosis","volume":"94","author":"Tao","year":"2018","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.trsl.2026.01.002_bib0036","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1053\/j.ajkd.2009.08.019","article-title":"Phase 1 trial of Adalimumab in focal segmental glomerulosclerosis (FSGS): II. Report of the FONT (novel therapies for resistant FSGS) study group","volume":"55","author":"Joy","year":"2010","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1016\/j.trsl.2026.01.002_bib0037","doi-asserted-by":"crossref","first-page":"284","DOI":"10.34067\/KID.0000000635","article-title":"Precision medicine proof-of-concept study of a TNF inhibitor in FSGS and treatment-resistant minimal change disease","volume":"6","author":"Trachtman","year":"2025","journal-title":"Kidney360"},{"issue":"3","key":"10.1016\/j.trsl.2026.01.002_bib0038","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.coi.2008.03.003","article-title":"Cytokine-producing B lymphocytes-key regulators of immunity","volume":"20","author":"Lund","year":"2008","journal-title":"Curr Opin Immunol"},{"issue":"4","key":"10.1016\/j.trsl.2026.01.002_bib0039","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/nri2729","article-title":"Effector and regulatory B cells: modulators of CD4+ T cell immunity","volume":"10","author":"Lund","year":"2010","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"10.1016\/j.trsl.2026.01.002_bib0040","first-page":"347","article-title":"Increased production of interleukin 4 in children with simple idiopathic nephrotic syndrome","volume":"107","author":"Kang","year":"1994","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.trsl.2026.01.002_bib0041","doi-asserted-by":"crossref","unstructured":"Cheung W., Wei C.L., Seah C.C., Jordan S.C., Yap H.K. Atopy, serum IgE, and interleukin-13 in steroid-responsive nephrotic syndrome..Pediatr Nephrol Jun 2004;19(6):627-32. doi:10.1007\/s00467-004-1438-8.","DOI":"10.1007\/s00467-004-1438-8"},{"issue":"5","key":"10.1016\/j.trsl.2026.01.002_bib0042","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1053\/j.ajkd.2009.03.019","article-title":"Idiopathic nephrotic syndrome and atopy: is there a common link?","volume":"54","author":"Abdel-Hafez","year":"2009","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1016\/j.trsl.2026.01.002_bib0043","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1053\/j.ajkd.2021.10.004","article-title":"Quantification of glomerular structural lesions: associations with clinical outcomes and transcriptomic profiles in nephrotic syndrome","volume":"79","author":"Hodgin","year":"2022","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1016\/j.trsl.2026.01.002_bib0044","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/ckj\/sfab270","article-title":"Precision medicine for the treatment of glomerulonephritis: a bold goal but not yet a transformative achievement","volume":"15","author":"Glassock","year":"2022","journal-title":"Clin Kidney J"},{"issue":"8","key":"10.1016\/j.trsl.2026.01.002_bib0045","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.34067\/KID.0000000000000499","article-title":"Minimal change disease and FSGS are a spectrum of a single disease within Immune-mediated nephrotic Syndrome","volume":"5","author":"Sim","year":"2024","journal-title":"Kidney360"},{"issue":"6","key":"10.1016\/j.trsl.2026.01.002_bib0046","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1681\/ASN.2021111472","article-title":"Long-term efficacy and safety of repeated rituximab to maintain remission in idiopathic childhood nephrotic syndrome: an international study","volume":"33","author":"Chan","year":"2022","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.trsl.2026.01.002_bib0047","first-page":"939","article-title":"Sequential rituximab therapy sustains remission of nephrotic syndrome but carries high risk of adverse effects","volume":"38","author":"Sinha","year":"2023","journal-title":"Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc"},{"issue":"1","key":"10.1016\/j.trsl.2026.01.002_bib0048","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00467-018-4063-7","article-title":"Periodically repeated rituximab administrations in children with refractory nephrotic syndrome: 2-year multicenter observational study","volume":"34","author":"Takahashi","year":"2019","journal-title":"Pediatr Nephrol"},{"issue":"2","key":"10.1016\/j.trsl.2026.01.002_bib0049","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1093\/ckj\/sfy067","article-title":"Continuous B-cell depletion in frequently relapsing, steroid-dependent and steroid-resistant nephrotic syndrome","volume":"12","author":"Cortazar","year":"2019","journal-title":"Clin Kidney J"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524426000010?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524426000010?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T08:14:59Z","timestamp":1778832899000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931524426000010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":49,"alternative-id":["S1931524426000010"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2026.01.002","relation":{},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"B-cell activation underpins Rituximab response in focal segmental glomerulosclerosis","name":"articletitle","label":"Article Title"},{"value":"Translational Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trsl.2026.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}